Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab VedotinCarissa Chu, Jonathan Chou|Clinical Cancer Research|2021Cited by 154
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Rahul Aggarwal|Cancer Research|2022Cited by 58
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasisPayam Shahi, Zena Werb, Jonathan Chou et al.|Oncogene|2017Cited by 50
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Xuhong Cao et al.|Cell Reports Medicine|2024Cited by 28
Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial CancerVadim S. Koshkin, Thomas A. Hope, Vipul Kumar et al.|Journal of Nuclear Medicine|2024Cited by 26